Inactive Instrument

Sector Chart Gene Biotherapeutics, Inc. Other OTC

Equities

CRXM

US8767671048

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
55.7B -
39.91B
39.57B
28.16B
26.3B
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW